172 related articles for article (PubMed ID: 24236332)
1. Meeting of the WHO expert working group on surveillance of influenza antiviral susceptibility, Geneva, July 2013.
Wkly Epidemiol Rec; 2013 Nov; 88(44/45):477-82. PubMed ID: 24236332
[No Abstract] [Full Text] [Related]
2. Meetings of the WHO working group on surveillance of influenza antiviral susceptibility – Geneva, November 2011 and June 2012.
Wkly Epidemiol Rec; 2012 Sep; 87(39):369-74. PubMed ID: 23061103
[No Abstract] [Full Text] [Related]
3. Executive summary of the 6th meeting of the WHO Expert Working Group of the GISRS for Surveillance of Antiviral Susceptibility.
Wkly Epidemiol Rec; 2017 Oct; 92(41):611-2. PubMed ID: 29028165
[No Abstract] [Full Text] [Related]
4. WHO Global Influenza Surveillance and Response System working group on surveillance of influenza antiviral susceptibility.
Wkly Epidemiol Rec; 2015 Aug; 90(33):414-9. PubMed ID: 26281047
[No Abstract] [Full Text] [Related]
5. [M2 inhibitors and neuraminidase inhibitors].
Klebe G; Schlitzer M
Pharm Unserer Zeit; 2011 Mar; 40(2):144-50. PubMed ID: 21630541
[No Abstract] [Full Text] [Related]
6. [High prevalence of antiviral resistant influenza, and reduced clinical effectiveness of the antivirals against resistant influenza strains].
Saito R
Jpn J Antibiot; 2010 Feb; 63(1):81-91. PubMed ID: 20836406
[No Abstract] [Full Text] [Related]
7. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.
Lackenby A; Besselaar TG; Daniels RS; Fry A; Gregory V; Gubareva LV; Huang W; Hurt AC; Leang SK; Lee RTC; Lo J; Lollis L; Maurer-Stroh S; Odagiri T; Pereyaslov D; Takashita E; Wang D; Zhang W; Meijer A
Antiviral Res; 2018 Sep; 157():38-46. PubMed ID: 29981793
[TBL] [Abstract][Full Text] [Related]
8. Influenza virus resistance to antiviral therapy.
van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
[TBL] [Abstract][Full Text] [Related]
9. [Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].
Reina J
Rev Esp Quimioter; 2006 Dec; 19(4):317-22. PubMed ID: 17235399
[No Abstract] [Full Text] [Related]
10. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
Huang L; Zhou JF; Wei H; Shu YL
Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic control of influenza.
Stephenson I; Nicholson KG
J Antimicrob Chemother; 1999 Jul; 44(1):6-10. PubMed ID: 10459804
[No Abstract] [Full Text] [Related]
12. Antiviral resistance in influenza viruses: laboratory testing.
Laplante J; St George K
Clin Lab Med; 2014 Jun; 34(2):387-408. PubMed ID: 24856534
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
Puzelli S; Facchini M; Di Martino A; Fabiani C; Lackenby A; Zambon M; Donatelli I
Antiviral Res; 2011 Jun; 90(3):205-12. PubMed ID: 21514326
[TBL] [Abstract][Full Text] [Related]
14. [Targeted drugs against influenza--how will this affect the epidemics?].
Pyhälä R; Ziegler T; Lumio J
Duodecim; 2000; 116(1):13-5. PubMed ID: 11764456
[No Abstract] [Full Text] [Related]
15. Antiviral drugs for seasonal influenza 2015-2016.
Med Lett Drugs Ther; 2015 Dec; 57(1484):169-71. PubMed ID: 26670552
[No Abstract] [Full Text] [Related]
16. Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.
Mishin VP; Hayden FG; Gubareva LV
Antimicrob Agents Chemother; 2005 Nov; 49(11):4515-20. PubMed ID: 16251290
[TBL] [Abstract][Full Text] [Related]
17. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
[TBL] [Abstract][Full Text] [Related]
18. Antiviral resistance in influenza viruses--implications for management and pandemic response.
Hayden FG
N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389
[No Abstract] [Full Text] [Related]
19. Resistance to neuraminidase inhibitors.
Dolin R
Clin Infect Dis; 2011 Feb; 52(4):438-9. PubMed ID: 21248366
[No Abstract] [Full Text] [Related]
20. [Antiviral resistance of influenza viruses].
Saito R; Suzuki H
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():471-5. PubMed ID: 17455665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
